1. Homepage
  2. Equities
  3. Canada
  4. CANADIAN NATIONAL STOCK EXCHANGE
  5. Cresco Labs Inc.
  6. Company
    CL   CA22587M1068

CRESCO LABS INC.

(CL)
  Report
Delayed CANADIAN NATIONAL STOCK EXCHANGE  -  05/20 03:59:59 pm EDT
5.290 CAD   +4.96%
05/19Piper Sandler Maintains Overweight Rating, US$9 TP on Cresco Labs
MT
05/18TRANSCRIPT : Cresco Labs Inc., Q1 2022 Earnings Call, May 18, 2022
CI
05/18Cresco Labs Announces First Quarter 2022 Results
BU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Cresco Labs Inc.
Cresco Labs Inc. is a cannabis operator in the United States. The Company is the wholesaler of branded cannabis products in the United States. Its brands include Cresco, High Supply, Mindy's Edibles, Good News, Remedi, Wonder Wellness Co. and FloraCal Farms. Sunnyside, the Company’s national dispensary brand, is a wellness-focused retailer. The Company operates in and/ or has ownership interests in Illinois, Pennsylvania, Ohio, California, Maryland, Arizona, New York, Massachusetts, Michigan and Florida.
Sales per Business
20202021Delta
Other Entities including Cresco Labs LLC518.0981.1%831.9880.8% +60.59%
MedMar Inc. (Rockford)51.538.1%106.4810.3% +106.65%
MedMar Inc. (Lakeview)42.016.6%60.725.9% +44.55%
Cresco Labs Ohio, LLc19.643.1%28.412.8% +44.62%
TSC Cresco, LLC22.633.5%27.022.6% +19.37%
SLO Cultivation Inc.26.524.2%26.342.6% -0.67%
CAD in Million
Sales per region
20202021Delta
United States626.0298%1 026.0599.6% +63.9%
Canada12.782%4.120.4% -67.75%
CAD in Million
Managers
Name Title Age Since
Charles Bachtell Chief Executive Officer & Director 42 2015
Dennis Marin Olis Chief Financial Officer 58 2020
Ty Gent Chief Operating Officer 61 2021
Megan W. Kulick Senior Vice President-Investor Relations - -
Gregory Butler Chief Commercial Officer 41 2020
Todd West Senior VP-Product Development & Commercialization - -
Anthony Casaccio Attorney - -
Donny Trivisonno Exec Vice President-Planning, Insights & Analytics - -
John P. Schetz General Counsel 44 2018
Emily Fitzgerald Director-Human Resources - 2019
Members of the board
Name Title Age Since
Thomas Joseph Manning Executive Chairman 65 2020
Randy D. Podolsky Independent Director 65 2016
Gerald Francis Corcoran Independent Director 66 2017
Robert M. Sampson Independent Director 46 2015
John Robert Walter, Dr. Independent Director 73 2017
Sidney Dillard Independent Director 45 2021
Charles Bachtell Chief Executive Officer & Director 42 2015
Michele Antoinette Roberts Director 64 2020
Marc Lustig Director 47 2020
Tarik Brooks Director 45 2021
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 272,636,000 252,853,697 92.7% 0 0.0% 63.0%
Stock B 0 20,472,000 0 0.0% 0 0.0%
Stock C 0 500,000 0 0.0% 0 0.0%
Stock D 0 107,740,000 0 0.0% 0 0.0%
Shareholders
NameEquities%
Marc Lustig 63,868,296 23.7%
Cowen & Co. LLC 14,146,336 5.24%
Joseph Caltabiano 3,123,700 1.16%
Wasatch Advisors, Inc. 2,738,723 1.01%
StoneCastle Investment Management, Inc. 1,219,300 0.45%
Intrepid Capital Management, Inc. (Florida) 380,505 0.14%
Charles Bachtell 283,886 0.11%
Ancora Family Wealth Advisors LLC 244,634 0.091%
Robert M. Sampson 200,000 0.074%
EMC Capital Management LLC 181,262 0.067%
Company contact information
Cresco Labs, Inc.
400 West Erie Street
Suite 110
Chicago, IL 60654

Phone : +1.312.929.0993
Web : http://www.crescolabs.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Cresco Labs Inc.
Sector Other Pharmaceuticals
1st jan.Capi. (M$)
CRESCO LABS INC.-36.95%1 212
JOHNSON & JOHNSON1.68%465 705
PFIZER, INC.-11.14%294 404
ELI LILLY AND COMPANY8.19%269 013
ABBVIE INC.11.53%266 851
ROCHE HOLDING AG-15.67%266 707
NOVO NORDISK A/S3.58%245 099
MERCK & CO., INC.22.06%236 570
ASTRAZENECA PLC20.93%202 681
NOVARTIS AG8.00%193 025
BRISTOL-MYERS SQUIBB COMPANY22.20%162 213
SANOFI15.49%134 759
AMGEN INC.10.01%132 214
GLAXOSMITHKLINE PLC9.80%111 286
BAYER AG35.62%66 062
DAIICHI SANKYO CO., LTD.13.20%49 636
CHUGAI PHARMACEUTICAL CO., LTD-5.33%45 478
TAKEDA PHARMACEUTICAL COMPANY LIMITED18.87%45 016
JIANGSU HENGRUI MEDICINE CO., LTD.-40.37%28 822
ASTELLAS PHARMA INC.4.92%27 643
ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD-30.05%27 566